Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Connetics Corporation

Connetics Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative therapeutics for the dermatology market. The Company's marketed products are OLUX® (clobetasol propionate) Foam, 0.05% and Luxiq® (betamethasone valerate) Foam, 0.12%, Evoclin™ (clindamycin phosphate) Foam 1%, and Soriatane® (acitretin) capsules. Connetics is developing Extina® , a foam formulation of the antifungal drug ketoconazole, Velac® Gel, a combination of clindamycin and tretinoin for treating acne, and Desilux™, a low-potency topical steroid, formulated with 0.05% desonide in the Company's proprietary emollient foam delivery vehicle. Connetics has branded its innovative foam drug delivery vehicle VersaFoam®. Our product formulations aim to improve the management of dermatological diseases and provide significant product differentiation, and have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance


Contact Details:
3160 Porter Drive
Palo Alto
California
94304
United States of America
Tel:1-650-843-2800
Fax:1-650-843-2899
Email:
WWW:

www.connetics.com/




Loading...

Recent Publications by Connetics Corporation:

A novel foam vehicle for delivery of topical corticosteroids.
Skin, particularly the uppermost layer--the stratum corneum--presents a...
11th November, 2005
Center for Skin Biology, Connetics Corp, Palo Alto, California 94303, USA. J Am Acad Dermatol. 2005 Jul;53(1 Suppl 1):S26-38.
DOI Direct Link
Simultaneous determination of tretinoin and clindamycin phosphate and their degradation products in topical formulations by reverse phase HPLC.
A new HPLC method based on reverse phase separation and photodiode-array...
9th October, 2004
Connetics Australia Pty. Ltd, 8 Macro Crt, Rowville, VIC 3178, Australia. J Sep Sci. 2004 Jan;27(1-2):71-7.
Bioavailability of clobetasol propionate in different vehicles.
Topical clobetasol propionate is widely used for the treatment of...
11th October, 2003
Connetics Corporation, Palo Alto, Calif., USA. Skin Pharmacol Appl Skin Physiol. 2003 Jul-Aug;16(4):212-6.
DOI Direct Link
Relaxin activates the MAP kinase pathway in human endometrial stromal cells.
The reproductive hormone, relaxin, is structurally similar to insulin and...
26th November, 2002
Connetics Corporation, 3400 West Bayshore Rd., Palo Alto, California J Cell Biochem. 2002;85(3):536-44.
DOI Direct Link
Systemic administration of recombinant human relaxin (RHRLX) ameliorates the acute cyclosporine nephrotoxicity in rats.
The reproductive hormone, relaxin, is structurally similar to insulin and...
16th March, 2001
Connetics Corporation, Palo Alto, CA, USA J Heart Lung Transplant. 2001 Feb;20(2):253.

View more Connetics Corporation research publications.

Press Releases on Connetics Corporation:

BioPortfolio Logo
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development 7th July, 2009 OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., July 7 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the
Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board 19th May, 2009 Techne Corporation
MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH) today announced that Mr. John L. Higgins has accepted a position on Techne's Board of Directors and will also serve
Excaliard Pharmaceuticals Appoints Lincoln Krochmal, MD, President & Chief Executive Officer and Jeffrey Jenson, Head of Clinical Operations. 10th October, 2008 Excaliard Pharmaceuticals
CARLSBAD, Calif., Oct. 10 /PRNewswire/ -- Excaliard Pharmaceuticals, a late stage preclinical company developing targeted therapeutics for the treatment of dermatological disorders and fibrotic

Connetics Corporation Clinical Trials:

Acitretin and Etanercept in Psoriasis

Connetics Corporation Patents:

US Patent No.Title
7222754 Aerosol system having lockable cap
5776459 TCR V beta 5 peptides
5811395 Relaxin analogs and derivatives methods and uses thereof
5911997 Relaxin-like factor and methods and uses thereof
6200953 Relaxin analogs and derivatives compositions

View more Connetics Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 581 times since April 2007, the link to the organisation's website has been followed 86 times

Recent Search Terms used to find this page: connetics pharmaceuticals | connetics pharmaceuticals | connetics california pharma | 16. Connetics Corporation (2004). Soriatane (acitretin) capsules. Complete product information. | desonide degradation HPLC | desonide degradation HPLC | Connetics | connetics | connetics | Connetics pharma | .

Search for more companies in Palo Alto

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Connetics Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.